Rare diseases
Investigational molecules
Locations
Back to Slovakia20 clinical trials in Levice, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study on the Safety and Effectiveness of AZD8630 for Adults with Uncontrolled Asthma at Risk of Exacerbations
SlovakiaStudy on the Effects of Itepekimab in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
SlovakiaStudy of remibrutinib for long-term treatment of adult patients with chronic spontaneous urticaria who completed previous remibrutinib studies
SlovakiaStudy on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma
SlovakiaStudy on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)
SlovakiaStudy on the Long-term Effects of Dupilumab in Preventing Lung Function Decline in Adults with Uncontrolled Moderate to Severe Asthma
SlovakiaStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
SlovakiaStudy on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
In Levice, cardiovascular disease research focuses on preventing serious events such as stroke, heart attack, and other vascular complications. These studies are designed to assess new options for stroke prevention, atherosclerotic cardiovascular disease, and related risk reduction.
The trials are mainly evaluating whether new treatments can improve protection against major cardiovascular events and support better long-term outcomes.
A large share of the clinical research in Levice is centered on asthma and chronic obstructive pulmonary disease. These studies explore ways to improve breathing control, reduce flare-ups, and slow the decline in lung function in people with persistent respiratory symptoms.
Overall, the research is aimed at testing new therapies and combination treatments that may help people breathe more easily and stay stable for longer.
Clinical trials in this area examine overweight, obesity, type 2 diabetes, and hyperlipidemia. The goal is to better understand treatment approaches that may support weight reduction and improve metabolic health.
These studies are mainly testing whether newer therapies can improve key health markers and reduce the burden of metabolic disease.
Research in skin and connective tissue diseases is represented by studies on chronic spontaneous urticaria. The main purpose is to evaluate treatments that may improve symptom control and provide longer-lasting relief for people with persistent allergic skin disease.
This area adds a focused immunology component to the clinical trial landscape in Levice.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
